Beximco, Eskayef launch Pfizer’s anti-Covid pill | The Business Standard
Skip to main content
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Monday
July 14, 2025

Sign In
Subscribe
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
MONDAY, JULY 14, 2025
Beximco, Eskayef launch Pfizer’s anti-Covid pill

Covid-19 in Bangladesh

TBS Report
30 December, 2021, 04:35 pm
Last modified: 30 December, 2021, 10:04 pm

Related News

  • Beximco Pharma's share price plummets 47% since July
  • What Beximco Pharma says to London Stock Exchange about unrest impact
  • Beximco Pharma secures €24.9m for business expansion
  • Beximco Pharma’s revenue surges 12% in July-Dec
  • Beximco Pharma on Forbes list of best companies in Asia

Beximco, Eskayef launch Pfizer’s anti-Covid pill

The medicine showed almost 90% efficacy in preventing hospitalisations and deaths in high-risk patients

TBS Report
30 December, 2021, 04:35 pm
Last modified: 30 December, 2021, 10:04 pm
Beximco, Eskayef launch Pfizer’s anti-Covid pill

Beximco and Eskayef, two leading pharmaceutical companies in the country, have separately announced the launch of Pfizer's oral antiviral medication – Paxlovid – for the treatment of Covid-19.

Beximco Pharmaceuticals Limited will market the drug under the brand name of Bexovid, while Eskayef will market it as Paxovir.

Both companies made their announcements on Thursday after the Directorate General of Drug Administration (DGDA) granted emergency use authorisation for the drug to treat mild-to-moderate Covid-19 patients including adults and children aged 12 years and above.

The Business Standard Google News Keep updated, follow The Business Standard's Google news channel

Earlier on 22 December, the US Food and Drug Administration (FDA) granted emergency use authorisation to the drug as the first approved oral therapy for Covid-19 treatment.

This novel antiviral pill showed almost 90% efficacy in preventing hospitalisations and deaths in high-risk patients, and recent lab data suggests the drug retains its effectiveness against the fast spreading Omicron variant of the coronavirus. 

The drug is co-packaged with nirmatrelvir and ritonavir tablets.

Nirmatrelvir inhibits a SARS-CoV-2 enzyme to stop the virus from replicating, and ritonavir slows down nirmatrelvir's breakdown to help it remain in the body for a longer period at higher concentrations.

The treatment is given as two tablets of nirmatrelvir and one tablet of ritonavir together twice a day for five days. Bexovid is available by prescription only and should be initiated as soon as possible after diagnosis of Covid-19 and within five days of symptom onset. 

Nazmul Hassan, managing director of Beximco Pharmaceuticals, commented, "Having previously introduced the world's first generic Covid-19 treatments of remdesivir and molnupiravir, we are pleased to add this breakthrough therapy to our portfolio.

"It is further testament to our commitment to making affordable treatments accessible as soon as possible. As data continues to emerge demonstrating the effectiveness of nirmatrelvir and ritonavir against the fast-emerging Omicron variant, we believe that Bexovid has the potential to be a powerful tool in combating the ongoing pandemic."

Simeen Rahman, managing director and CEO of Eskayef Pharmaceuticals Limited, said, "Since the beginning of the pandemic Eskayef has been trying to deliver drugs, which are effective for treatment against the coronavirus. This new drug is a part of that ongoing effort."

Earlier on 9 November, The DGDA granted Beximco, Square, Eskayef and Renata the approval for the production and marketing of molnupiravir, the first-ever Covid-19 pill developed by US drugmaker Merck & Co Inc and Ridgeback Biotherapeutics. Molnupiravir is now available in the country's domestic market.

Bangladesh / Top News / Health

Paxlovid / Beximco Pharmaceuticals Limited

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • File photo of Commerce Adviser Sheikh Bashir Uddin. Photo: BSS
    Bangladesh hopes for 'rational' US tariffs, confident of sustaining trade ties: Commerce adviser
  • Hundreds of leaders and activists of BNP's Dhaka Metropolitan North and South units bring out processions in the capital this afternoon (14 July). Photo: Mehedi Hasan
    BNP, Chhatra Dal hold massive rally protesting propaganda against Tarique, demanding justice over Mitford murder
  • Selim Jahan. Sketch: TBS
    What challenges await the Bangladesh economy?

MOST VIEWED

  • From Gulf to Southeast Asia, why Bangladeshis are facing visa denials
    From Gulf to Southeast Asia, why Bangladeshis are facing visa denials
  • Infographic: TBS
    Dollar price plummets by Tk2.9 in a week as demand wanes
  • Energy Adviser Fouzul Kabir Khan speaking about tariff negotiations with United States on 13 July 2025. Photo: TBS
    US wants a framework agreement with Bangladesh that includes their security concerns: Fouzul
  • CNG drivers blockaded a road in Banani demanding route allocation on 13 July 2025. Photo: TBS
    CNG drivers block road in Banani for hours, causing Mohakhali-Uttara gridlock 
  • BSEC directs 44 firms to transfer Tk1,000cr in unclaimed dividends to CMSF
    BSEC directs 44 firms to transfer Tk1,000cr in unclaimed dividends to CMSF
  • TBS Sketch
    Framework agreement: What experts say about US 'security concerns' regarding Bangladesh

Related News

  • Beximco Pharma's share price plummets 47% since July
  • What Beximco Pharma says to London Stock Exchange about unrest impact
  • Beximco Pharma secures €24.9m for business expansion
  • Beximco Pharma’s revenue surges 12% in July-Dec
  • Beximco Pharma on Forbes list of best companies in Asia

Features

DU students at TSC around 12:45am on 15 July 2024, protesting Sheikh Hasina’s insulting remark. Photo: TBS

‘Razakar’: The butterfly effect of a word

3h | Panorama
Photo: Collected

Grooming gadgets: Where sleek tools meet effortless styles

1d | Brands
The 2020 Harrier's Porsche Cayenne coupe-like rear roofline, integrated LED lighting with the Modellista special bodykit all around, and a swanky front grille scream OEM Plus for the sophisticated enthusiast looking for a bigger family car that isn’t boring. PHOTO: Ahbaar Mohammad

2020 Toyota Harrier Hybrid: The Japanese Macan

2d | Wheels
The showroom was launched through a lavish event held there, and in attendance were DHS Motors’ Managing Director Nafees Khundker, CEO Imran Zaman Khan, and GMs Arman Rashid and Farhan Samad. PHOTO: Akif Hamid

GAC inaugurate flagship showroom in Dhaka

2d | Wheels

More Videos from TBS

From fuels to fruits, imports slump on depressed demand

From fuels to fruits, imports slump on depressed demand

48m | TBS Insight
Is France increasing defense budget fear of Russia?

Is France increasing defense budget fear of Russia?

1h | TBS World
EU delays retaliatory tariffs against US amid hopes for trade deal

EU delays retaliatory tariffs against US amid hopes for trade deal

2h | TBS World
Well-orchestrated propaganda launched against BNP to prevent restoration of democratic politics: Fakhrul

Well-orchestrated propaganda launched against BNP to prevent restoration of democratic politics: Fakhrul

3h | TBS Today
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net